-
Norgen Biotek Transitions into Diagnostics with the Launch of over 30 New Kits for Nucleic Acid-Based Diagnostics
THOROLD, ON, March 18 /PRNewswire/ - Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acids (NA) and protein purification, today announced the launch of over 30 new kits for nucleic-acid based diagnostics. Nor
-
MedeFile Adds International Biotech Expert to Advisory Board
BOCA RATON, Fla., March 18 /PRNewswire-FirstCall/ -- MedeFile International, Inc. (OTC Bulletin Board: MDFI), a leader in portable electronic medical records management, announced today the addition of internationally-renowned biotechnology veteran Dr. Gurinder Shahi, M.D., Ph.D., to its Advisory Bo
-
Moffitt Cancer Center Signs Licensing Agreement with Proteacel, LLC
TAMPA, Fla., March 18 /PRNewswire/ -- Moffitt Cancer Center and Proteacel LLC announced today that they have entered a licensing agreement under which Proteacel has acquired the exclusive rights to the PORE™ technology for delivery of genes into cells.
Genes are the instructions that bu
-
Marc Kamin, M.D. Joins PharmaNet Development Group as Vice President, Medical and Scientific Affairs, Neuroscience
PRINCETON, N.J., March 18 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, announced today that Marc Kamin, M.D., has been appointed Vice President, Medical and Scientif
-
More Research Needed to Determine Best Treatment of Multi-Vessel Coronary Artery Disease During Primary PCI for ST-Segment Elevation Myocardial Infarction
ATLANTA, March 18 /PRNewswire/ -- Nearly 14 percent of Medicare beneficiaries admitted with a primary diagnosis of ST-Segment Elevation Myocardial Infarction (STEMI) undergo multi-vessel primary percutaneous coronary intervention (PCI), despite recommendations from the American College of Cardiology
-
PROLOR Biotech Announces Sale of $24.4 Million of Common Stock
NES-ZIONA, Israel, March 18 /PRNewswire-FirstCall/ -- PROLOR Biotech, Inc., (OTC Bulletin Board: PBTH), a company developing next generation biobetter therapeutic proteins, today announced that it has raised $24.4 million in a private placement of 10,382,975 shares of its common stock, par val
-
Celsion Corporation Announces ThermoDox(R) Abstract Accepted for Presentation at the American Society of Clinical Oncology 2010 Annual Meeting
COLUMBIA, Md., March 18 /PRNewswire-FirstCall/ -- Celsion Corporation (Nasdaq: CLSN) today announced that an abstract about the Phase I/II trial of ThermoDox® in Recurrent Chest Wall Cancer (RCW) has been accepted for presentation at the American Society of Clinical Oncology (ASCO) 2010 Annual
-
Continued Demand Makes Monsanto and Agriculture Unique Investment Opportunities, Global Seeds and Traits Lead to Tell Investors
ST. LOUIS, March 18, 2010 /PRNewswire-FirstCall/ -- As world population growth and dietary shifts continue, Monsanto Company's (NYSE: MON) ongoing investment in agriculture is bringing more choices to the farm than ever before, Brett Begemann, executive vice president – seeds and traits, will
-
Kendle Executive to Share Insights at World Pharma Trials Asia 2010
CINCINNATI, March 17 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced Dr. Ross Horsburgh, Vice President, Asia/Pacific will address the World Pharma Trials Asia 2010 conference being held March 17-18, 2010 at the Raffles
-
Champions Biotechnology Reports Fiscal 2010 Third Quarter Financial Results
BALTIMORE, March 17 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today announced its financial results for the third fis
-
Kendle Announces New Revolving Credit Facility
CINCINNATI, March 17 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced that it has entered into a new $35 million secured revolving credit facility as of March 15, 2010 with JPMorgan Chase Bank N.A., as administrative agen
-
OriGene Technologies Raises $16 Million to Build the Largest Collection of Next Generation Monoclonal Antibodies (TrueMAB(TM)) to Cover the Majority of Human Proteome
ROCKVILLE, Md., March 17 /PRNewswire/ -- OriGene Technologies, Inc., a leading gene-centric life sciences company, announced the completion of a $16 million Series B financing led by IDG-Accel, SBI & TH Venture Capital Enterprise, and Zero2IPO. OriGene's previous investors Morningside Vent
-
Idenix Pharmaceuticals to Present at the Barclays Capital 2010 Global Healthcare Conference
CAMBRIDGE, Mass., March 17 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that management will present a corporate overview at the upcoming Barclays Capital 2010 Global Healthcare Conference, March 24, 2010 at 8:30 a.m. ET at the Loews Miami Hotel, Florida.
The
-
Bioscience Bridge, LLC Launches as a Technology Transfer Agency for University-Based Bioscience Research
BOISE, Idaho, March 17 /PRNewswire/ -- A new professional services company has been launched focused on accelerating the connections of university-based bioscience research with commercial development opportunities. Bioscience Bridge, LLC was formed by Michelle Travis, principal and managing directo
-
Agendia to Play Pivotal Role in ISPY-2 Trial for Breast Cancer
12 Cancer Drugs Tested, 20 Leading U.S. Cancer Centers Involved
HUNTINGTON BEACH, California and AMSTERDAM, March 17, 2010 /PRNewswire/
-- Agendia, a world leader in molecular cancer diagnostics, announced today
it will participate in the highly anticipated I-SPY 2 TRIAL for breast
cancer,
-
From Donuts To Hogs - Which Brand Icons Might Be In Play?
NEW YORK, March 17 /PRNewswire/ -- Initial public offerings for LinkedIn and Dunkin Donuts, takeovers of Mead Johnson Nutrition and Harley-Davidson, and a Cold Stone Creamery sale are among the 10 deals predicted by columnists from Dow Jones Investment Banker for 2010.
"Technology should lead the m
-
Data Presented at ACC/i2 Summit Demonstrate Impressive Long Term Clinical Outcomes in Real World Patients Treated with OrbusNeich's Genous(TM) Bio-engineered R stent(TM)
ATLANTA, March 17 /PRNewswire/ -- OrbusNeich today announced that 12 month follow up data from real world patients demonstrated long term clinical efficacy of the company's Genous Bio-engineered R stent.
Margo Klomp, M.D., of the Academic Medical Center (AMC) in Amsterdam, presented the data from 40
-
Healthcare Web Site Expands Reach to Pharmacy Industry
DENVER, March 17 /PRNewswire/ -- HEALTHeCAREERS Network, North America's leading healthcare Network, has another solution for the down economy.
(Logo: http://www.newscom.com/cgi-bin/prnh/20100204/FL49504LOGO-a )
Employers are now able to post as many pharmacy-specific jobs as they would like through
-
Micromet Closes $80.5 Million Public Offering of Common Stock
BETHESDA, Md., March 17 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI) announced today the closing of its previously announced underwritten public offering. Prior to closing, the underwriters exercised in full their option to purchase an additional 1.5 million shares of common stock. As a r
-
Zimmer Holdings to Present at Barclays Capital 2010 Global Healthcare Conference
WARSAW, Ind., March 17 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH) announced today it will be participating in the Barclays Capital 2010 Global Healthcare Conference in Miami, Fla., on March 23, 2010, at 8:30 a.m. Eastern Time.
A live webcast of the presentation can
|